1. Home
  2. MRBK vs QNCX Comparison

MRBK vs QNCX Comparison

Compare MRBK & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meridian Corporation

MRBK

Meridian Corporation

HOLD

Current Price

$18.32

Market Cap

198.4M

Sector

Finance

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$3.06

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRBK
QNCX
Founded
2004
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.4M
167.0M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
MRBK
QNCX
Price
$18.32
$3.06
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$18.00
$7.67
AVG Volume (30 Days)
67.6K
979.1K
Earning Date
01-23-2026
11-12-2025
Dividend Yield
2.73%
N/A
EPS Growth
75.95
N/A
EPS
1.77
N/A
Revenue
$109,758,000.00
N/A
Revenue This Year
$26.48
N/A
Revenue Next Year
$7.79
N/A
P/E Ratio
$10.36
N/A
Revenue Growth
18.84
N/A
52 Week Low
$11.16
$0.72
52 Week High
$19.24
$4.55

Technical Indicators

Market Signals
Indicator
MRBK
QNCX
Relative Strength Index (RSI) 60.47 47.31
Support Level $17.74 $2.85
Resistance Level $19.24 $3.72
Average True Range (ATR) 0.51 0.31
MACD 0.05 0.01
Stochastic Oscillator 59.14 41.38

Price Performance

Historical Comparison
MRBK
QNCX

About MRBK Meridian Corporation

Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: